Blackford and Nurea Announce Cardiovascular AI Partnership

Blackford and Nurea partner to integrate Nurea's PRAEVAorta® 2 solution with Blackford's AI platform, offering automated analysis of CT images for improved cardiovascular treatment and monitoring.

post image
Blackford and Nurea Announce Cardiovascular AI Partnership
1:41


We are delighted to announce a commercial partnership to bring Nurea’s PRAEVAorta® 2 solution to healthcare professionals via the Blackford Platform.
 
Under this strategic partnership, Nurea's innovative technology will be integrated with Blackford's enterprise AI platform. By integrating Nurea’s advanced AI tool, healthcare providers will gain access to automated analysis of CT images to enable better treatment and monitoring of cardiovascular pathologies.

Nurea is dedicated to revolutionizing cardiovascular healthcare, specializing in software development for the analysis of CT scans. The PRAEVAorta® 2 software allows surgeons to immediately visualize the status of the aorta through geometrical data, helping them make accurate and reliable diagnosis easier, faster and earlier.
 
"Nurea's commitment to the detection and prevention of cardiovascular accidents fits perfectly with our mission to improve the lives of patients and populations by leveraging AI to drive healthcare efficiencies", said Ben Panter, Founder and CEO of Blackford. "We’re therefore delighted to add Nurea’s PRAEVAorta® 2 application to the extensive portfolio of solutions available via our tried-and-tested AI platform.”

“We are delighted to initiate this new collaboration with the Blackford team and benefit from their historic position as a reference provider of AI solutions to medical centers”, said Florian Bernard, co-founder and CEO of Nurea. “We see the partnership with Blackford as a real game changer in our go-to-market strategy to speed up the commercialization of Nurea’s solutions to radiologists and vascular surgeons, both in EU and North America.”